Federica Rossin

10PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Water treatment processesPredictive and prognostic markersMolecular medicineChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 21, 2026
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.

Francesca Barberini, Riccardo Pietroni, Simone Ielpo

|Oct 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.

Francesca Barberini, Riccardo Pietroni, Simone Ielpo

|Apr 10, 2025
Epigenetic modulation of RIPK3 by transglutaminase 2-dependent serotonylation of H3K4me3 affects necroptosis.

Alessio Vecchio, Fiorella Colasuonno, Luca Occhigrossi

|Oct 29, 2023
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.

Silvia Muccioli, Valentina Brillo, Tatiana Varanita

|Jan 21, 2023
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin.

Ivana Palucci, Alessandro Salustri, Flavio De Maio

|Dec 26, 2022
Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells.

Luca Occhigrossi, Manuela D'Eletto, Alessio Vecchio

Pageof 2

Frequent Collaborators

3 joint publications

Luca Occhigrossi

3 joint publications

Mauro Piacentini

3 joint publications

Manuela D'Eletto

2 joint publications

Ivana Palucci